Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Jones

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Cell|December 14, 2011
Polycomb-repressed genes have permissive enhancers that initiate reprogrammingPhillippa C Taberlay, Theresa K Kelly, Chun-Chi Liu, et al.
Genome Research|February 12, 2014
Reprogramming of the human intestinal epigenome by surgical tissue transpositionFides D Lay, Timothy J Triche, Yvonne C Tsai, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in miceChristine B Yoo, Jody C Chuang, Hyang-Min Byun, et al.
Cancer Research|April 5, 2020
Activation of a Subset of Evolutionarily Young Transposable Elements and Innate Immunity Are Linked to Clinical Responses to 5-AzacytidineHitoshi Ohtani, Andreas D Ørskov, Alexandra S Helbo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrenceSheng-Fang Su, André Luís de Castro Abreu, Yoshitomo Chihara, et al.
Molecular Cancer Research : MCR|May 12, 2005
Discovery of epigenetically masked tumor suppressor genes in endometrial cancerNoriyuki Takai, Norihiko Kawamata, Christine S Walsh, et al.
Cancer Cell|August 25, 2004
Preferential response of cancer cells to zebularineJonathan C Cheng, Christine B Yoo, Daniel J Weisenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genomeGangning Liang, Joy C Y Lin, Vivian Wei, et al.
The Journal of Pathology|June 29, 2004
Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancerSunanda J Chatterjee, Ben George, Peter J Goebell, et al.
Cell|August 29, 2015
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous TranscriptsDavid Roulois, Helen Loo Yau, Rajat Singhania, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Cell|December 14, 2011
Polycomb-repressed genes have permissive enhancers that initiate reprogrammingPhillippa C Taberlay, Theresa K Kelly, Chun-Chi Liu, et al.
Genome Research|February 12, 2014
Reprogramming of the human intestinal epigenome by surgical tissue transpositionFides D Lay, Timothy J Triche, Yvonne C Tsai, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in miceChristine B Yoo, Jody C Chuang, Hyang-Min Byun, et al.
Cancer Research|April 5, 2020
Activation of a Subset of Evolutionarily Young Transposable Elements and Innate Immunity Are Linked to Clinical Responses to 5-AzacytidineHitoshi Ohtani, Andreas D Ørskov, Alexandra S Helbo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrenceSheng-Fang Su, André Luís de Castro Abreu, Yoshitomo Chihara, et al.
Molecular Cancer Research : MCR|May 12, 2005
Discovery of epigenetically masked tumor suppressor genes in endometrial cancerNoriyuki Takai, Norihiko Kawamata, Christine S Walsh, et al.
Cancer Cell|August 25, 2004
Preferential response of cancer cells to zebularineJonathan C Cheng, Christine B Yoo, Daniel J Weisenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genomeGangning Liang, Joy C Y Lin, Vivian Wei, et al.
The Journal of Pathology|June 29, 2004
Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancerSunanda J Chatterjee, Ben George, Peter J Goebell, et al.
Cell|August 29, 2015
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous TranscriptsDavid Roulois, Helen Loo Yau, Rajat Singhania, et al.
Pageof 17